| Treatment-related adverse events of combination immune checkpoint inhibitors: systematic review and meta-analysis R Park, L Lopes, CR Cristancho, IM Riano, A Saeed Frontiers in oncology 10, 258, 2020 | 48 | 2020 |
| Comparison of efficacy of systemic therapies in advanced hepatocellular carcinoma: updated systematic review and frequentist network meta-analysis of randomized controlled trials R Park, L Lopes da Silva, V Nissaisorakarn, I Riano, S Williamson, W Sun, ... Journal of Hepatocellular Carcinoma, 145-154, 2021 | 14 | 2021 |
| Stevens-Johnson syndrome–like reaction after exposure to Pembrolizumab and recombinant zoster vaccine in a patient with metastatic lung cancer I Riano, C Cristancho, T Treadwell Journal of investigative medicine high impact case reports 8, 2324709620914796, 2020 | 14 | 2020 |
| Incidence, mortality, and survival trends of primary CNS tumors in Cali, Colombia, from 1962 to 2019 I Riano, P Bravo, LE Bravo, LS Garcia, P Collazos, E Carrascal JCO global oncology 6, 1712-1720, 2020 | 9 | 2020 |
| Race/ethnicity and gender representation in hematology and oncology editorial boards: What is the state of diversity? SR Patel, I Riano, I Abuali, A Ai, G Geiger, J Pimienta, A Ramirez Roggio, ... The Oncologist 28 (7), 609-617, 2023 | 6 | 2023 |
| The Prognostic and Predictive Impact of BRAF Mutations in Deficient Mismatch Repair/Microsatellite Instability-High Colorectal Cancer: Systematic Review/Meta … R Park, L Lopes, S Lee, I Riano, A Saeed Future Oncology 17 (31), 4221-4231, 2021 | 6 | 2021 |
| Lung cancer in women: the past, present, and future N Florez, L Kiel, I Riano, S Patel, K DeCarli, N Dhawan, I Franco, ... Clinical Lung Cancer, 2023 | 5 | 2023 |
| Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload A Kondrashov, S Sapkota, A Sharma, I Riano, R Kurzrock, JJ Adashek Pharmaceutics 15 (8), 2160, 2023 | 5 | 2023 |
| HOLA COVID-19 study: evaluating the impact of caring for patients with COVID-19 on cancer care delivery in Latin America C Bernabe-Ramirez, AI Velazquez, C Olazagasti, C Decat Bergerot, ... JCO global oncology 8, e2100251, 2022 | 4 | 2022 |
| Where are the women and underrepresented minorities in medicine? Race/ethnicity and gender representation in oncology journals’ editorial boards. SR Patel, I Riano, G Geiger, J Pimienta, I Abuali, A Ai, A Ramirez Roggio, ... Journal of Clinical Oncology 39 (15_suppl), 11007-11007, 2021 | 4 | 2021 |
| Comparison of systemic therapy efficacy in advanced hepatocellular carcinoma: Systematic review and frequentist network meta-analysis of randomized controlled trials. R Park, L Lopes da Silva, V Nissaisorakarn, I Riano, A Saeed Journal of Clinical Oncology 39 (3_suppl), 293-293, 2021 | 4 | 2021 |
| Complete Resolution of a Large, Locally-advanced Cutaneous Squamous Cell Carcinoma with the Immune-modulating PD-1 Inhibitor Pembrolizumab C Cristancho, I Riano, D Guareras-Paredes, R Park, K Seetharaman Cureus 12 (5), 2020 | 4 | 2020 |
| Challenges faced by J-1 international medical graduates (IMGS) during Covid-19 pandemic F Abu Rous, I Riano Cancer investigation 41 (3), 249-252, 2023 | 3 | 2023 |
| Role of neoadjuvant immune checkpoint inhibitors in resectable non-small cell lung cancer I Riano, I Abuali, A Sharma, J Durant, KH Dragnev Pharmaceuticals 16 (2), 233, 2023 | 3 | 2023 |
| A rare cause of isolated prolonged activated partial thromboplastin time: an overview of prekallikrein deficiency and the contact system I Riano, K Prasongdee Journal of Investigative Medicine High Impact Case Reports 9, 23247096211012187, 2021 | 3 | 2021 |
| An overview of cervical cancer prevention and control in Latin America and the Caribbean countries I Riano, P Contreras-Chavez, CM Pabon, K Meza, L Kiel, S Bejarano, ... Hematology/Oncology Clinics 38 (1), 13-33, 2024 | 2 | 2024 |
| Evidence to date: evaluating pembrolizumab in the treatment of extensive-stage small-cell lung cancer I Riano, SR Patel, SV Liu, N Duma Clinics and Practice 11 (3), 441-454, 2021 | 2 | 2021 |
| State of Cancer Control in South America: Challenges and Advancement Strategies I Riano, AI Velazquez, L Viola, I Abuali, K Jimenez, O Abioye, N Florez Hematology/Oncology Clinics 38 (1), 55-76, 2024 | 1 | 2024 |
| The beginning of the perioperative immunotherapy era in early-stage non-small cell lung cancer I Riano, KH Dragnev, JD Phillips Translational Lung Cancer Research 12 (11), 2359, 2023 | 1 | 2023 |
| Self-identification of gender and race/ethnicity in hematology and oncology journal editorial boards: What is the state of diversity? I Riano, SR Patel, I Abuali, A Ai, G Geiger, J Pimienta, A Ramirez Roggio, ... Journal of Clinical Oncology 40 (16_suppl), 11058-11058, 2022 | 1 | 2022 |
